FierceBiotech Apr 15, 2026 Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors Original
Information Booth Information Booth German Pavilion (German Federal Ministry for Economic Affairs and Climate Action) News
Information Booth Information Booth German Pavilion (German Federal Ministry for Economic Affairs and Climate Action) News